Profil
Olivier Carli is currently the Chairman of Liventa Bioscience, Inc. He was previously the Chairman & Chief Executive Officer of Scient'x SA, Chairman of Curium PET France, and Chief Executive & Investor Relations Officer of Ideal Medical Products Engineering SASU from 2009 to 2011.
Aktive Positionen von Olivier Carli
| Unternehmen | Position | Beginn |
|---|---|---|
Liventa Bioscience, Inc.
Liventa Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides cellular and biologic products | Vorsitzender | - |
Ehemalige bekannte Positionen von Olivier Carli
| Unternehmen | Position | Ende |
|---|---|---|
Ideal Medical Products Engineering SASU
Ideal Medical Products Engineering SASU Medical SpecialtiesHealth Technology Supplies and provides medical equipment units | Präsident | - |
Curium PET France
Curium PET France Miscellaneous Commercial ServicesCommercial Services Offers resesarch in nuclear medicine in radio-pharmaceutics | Vorsitzender | - |
Scient'x SA
Scient'x SA Medical SpecialtiesHealth Technology Designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Liventa Bioscience, Inc.
Liventa Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides cellular and biologic products | Health Technology |
Ideal Medical Products Engineering SASU
Ideal Medical Products Engineering SASU Medical SpecialtiesHealth Technology Supplies and provides medical equipment units | Health Technology |
Scient'x SA
Scient'x SA Medical SpecialtiesHealth Technology Designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine | Health Technology |
Curium PET France
Curium PET France Miscellaneous Commercial ServicesCommercial Services Offers resesarch in nuclear medicine in radio-pharmaceutics | Commercial Services |
















